Review of the experience of using herbal drugs for the treatment of acute rhinosinusitis from the standpoint of evidence-based medicine
- Authors: Bachert C.1
-
Affiliations:
- University Hospital Ghent
- Issue: Vol 23, No 9 (2021)
- Pages: 430-440
- Section: Articles
- URL: https://journal-vniispk.ru/2075-1753/article/view/95496
- DOI: https://doi.org/10.26442/20751753.2021.9.200988
- ID: 95496
Cite item
Full Text
Abstract
Full Text
##article.viewOnOriginalSite##About the authors
Claus Bachert
University Hospital Ghent
Email: claus.bachert@ugent.be
профессор, глава лаборатории исследования верхних дыхательных путей Ghent, Belgium
References
- Fokkens WJ, Lund VJ, Mullol J, et al. EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012. A summary for otorhinolaryngologists. Rhinology. 2012;50:1-12. doi: 10.4193/Rhino50E2
- Worrall G. Acute sinusitis. Can Fam Physician. 2011;57:56577.
- Orlandi RR, Kingdom TT, Hwang PH. International consensus statement on allergy and rhinology: rhinosinusitis executive summary. Int Forum Allergy Rhinol. 2016;6(Suppl. 1):S3-21. doi: 10.1002/alr.21694
- Sharma P, Finley R, Weese S, et al. Antibiotic prescriptions for outpatient acute rhinosinusitis in Canada, 2007-2013. PLoS One. 2017;12:e0181957. doi: 10.1371/journal.pone.0181957
- Eisenberg DM, Davis RB, Ettner SL, et al. Trends in alternative medicine use in the United States, 19901997: results of a follow-up national survey. JAMA. 1998;280:1569-75. doi: 10.1001/jama.280.18.1569
- Guo R, Pittler MH, Ernst E. Herbal medicines for the treatment of allergic rhinitis: a systematic review. Ann Allergy Asthma Immunol. 2007;99:483-95. doi: 10.1016/S1081-1206(10)60375-4
- Koch AK, Klose P, Lauche R, et al. A systematic review of phytotherapy for acute rhinosinusitis. Forsch Komplementmed. 2016;23:165-9. doi: 10.1159/000447467
- Macchi A, Terranova P, Castelnuovo P. Recurrent acute rhinosinusitis: a single blind clinical study of N-acetylcysteine vs ambroxol associated to corticosteroid therapy. Int J Immunopathol Pharmacol. 2012;25:207-17. doi: 10.1177/039463201202500123
- Neubauer N, Marz RW. Placebo-controlled, randomized double-blind clinical trial with Sinupret(R) sugar coated tablets on the basis of a therapy with antibiotics and decongestant nasal drops in acute sinusitis. Phytomedicine. 1994;1:177-81. doi: 10.1016/S0944-7113(11)80061-9
- Rossi A, Dehm F, Kiesselbach C, et al. The novel Sinupret(R) dry extract exhibits antiinflammatory effectiveness in vivo. Fitoterapia. 2012;83:715720. doi: 10.1016/j.fitote.2012.02.008
- Marz RW, Ismail C, Popp MA. Profile and effectiveness of a phytogenic combination preparation for treatment of sinusitis. Wien Med Wochenschr. 1999;149:202-8.
- Melzer J, Saller R, Schapowal A, Brignoli R. Systematic review of clinical data with BNO-101 (Sinupret) in the treatment of sinusitis. Forsch Komplementmed. 2006;13:78-87. doi: 10.1159/000091969
- Jund R, Mondigler M, Stammer H, et al. Herbal drug BNO 1016 is safe and effective in the treatment of acute viral rhinosinusitis. Acta Otolaryngol. 2015;135:42-50. doi: 10.3109/00016489.2014.952047
- Jund R, Mondigler M, Steindl H, et al. Clinical efficacy of a dry extract of five herbal drugs in acute viral rhinosinusitis. Rhinology. 2012;50:417-26. doi: 10.4193/Rhino12.015
- Jund R, Mondigler M, Steindl H, et al. Clinical efficacy of a herbal drug combination in acute viral rhinosinusitis. MMW Fortschr Med. 2015;157:6-11. doi: 10.1007/s15006-015-2934-4
- Passali D, Loglisci M, Passali GC, et al. A prospective open-label study to assess the efficacy and safety of a herbal medicinal product (Sinupret) in patients with acute rhinosinusitis. ORL J Otorhinolaryngol Relat Spec. 2015;77:27-32. D0I:10.1159/000370123
- Weber U, Luedtke R, Friese KH, et al. A non-randomised pilot study to compare complementary and conventional treatments of acute sinusitis. Forsch Komplementarmed Klass Naturheilkd. 2002;9:99-104. doi: 10.1159/000057271
- Schoetz K, Erdelmeier C, Germer S, Hauer H. A detailed view on the constituents of EPs 7630. Planta Med. 2008;74:667-74. doi: 10.1055/s-2008-1074515
- Bladt S, Wagner H. From the Zulu medicine to the European phytomedicine Umckaloabo. Phytomedicine. 2007;14(Suppl. 6):2-4. DOI:10.1016/j. phymed.2006.11.030
- Kayser O, Kolodziej H, Kiderlen AF. Immunomodulatory principles of Pelargonium sidoides. Phytother Res. 2001;15:122-6. doi: 10.1002/ptr.785
- Michaelis M, Doerr HW, Cinatl J Jr. Investigation of the influence of EPs(R) 7630, a herbal drug preparation from Pelargonium sidoides, on replication of a broad panel of respiratory viruses. Phytomedicine. 2011;18:384-6. doi: 10.1016/j.phymed.2010.09.008
- Lizogub VG, Riley DS, Heger M. Efficacy of a Pelargonium sidoides preparation in patients with the common cold: a randomized, double blind, placebo-controlled clinical trial. Explore (NY). 2007;3:573-84. D0I:10.1016/j.explore.2007.09.004
- Riley DS, Lizogub VG, Zimmermann A, et al. Efficacy and tolerability of high-dose pelargonium extract in patients with the common cold. Altern Ther Health Med. 2018;24:16-26.
- Bachert C, Schapowal A, Funk P, Kieser M. Treatment of acute rhinosinusitis with the preparation from Pelargonium sidoides EPs 7630: a randomized, double-blind, placebo-controlled trial. Rhinology. 2009;47:51-8.
- Peric A, Gacesa D, Barac A, et al. Herbal drug EPs 7630 versus amoxicillin in patients with uncomplicated acute bacterial rhinosinusitis: a randomized, open-label study. Ann Otol Rhinol Laryngol. 2020;129:969-76. doi: 10.1177/0003489420918266
- Mullol J, Crespo C, Carre C, Brosa M. Pharmacoeconomics of Cyclamen europaeum in the management of acute rhinosinusitis. Laryngoscope. 2013;123:2620-5. doi: 10.1002/lary.24167
- Pfaar O, Mullol J, Anders C, et al. Cyclamen europaeum nasal spray, a novel phytotherapeutic product for the management of acute rhinosinusitis: a randomized double-blind, placebo-controlled trial. Rhinology. 2012;50(1):37-44. doi: 10.4193/Rhino10.096
- Ponikau JU, Hamilos DL, Barreto A, et al. An exploratory trial of Cyclamen europaeum extract for acute rhinosinusitis. Laryngoscope. 2012;122:1887-92. doi: 10.1002/lary.23366
- Gedevanishvili MD, Gogitidze NM, Sikharulidze IS. Reflex mechanisms of nasoparanasal secretion in administration of sinuforte. Vestn Otorinolaringol. 2007;(3):54-5.
- Zalmanovici Trestioreanu A, Barua A, Pertzov B. Cyclamen europaeum extract for acute sinusitis. Cochrane Database SystRev. 2018;5:CD011341. D0I:10.1002/14651858.CD011341.pub2
- Gottschlich S, Roschmann K, Candler H. Phytomedicines in acute rhinosinusitis: a prospective, non-interventional parallel-group trial. Adv Ther. 2018;35:1023-34. doi: 10.1007/s12325-018-0736-7
- Rantzsch U, Vacca G, Duck R, Gillissen A. Anti-inflammatory effects of Myrtol standardized and other essential oils on alveolar macrophages from patients with chronic obstructive pulmonary disease. Eur J Med Res. 2009;14(Suppl. 4):205-9. doi: 10.1186/2047-783x-14-s4-205
- Christoph F, Kaulfers PM, Stahl-Biskup E. In vitro evaluation of the antibacterial activity of betatriketones admixed to Melaleuca oils. Planta Med. 2001;67:768-71. doi: 10.1055/s-2001-18350
- Behrbohm H, Kaschke O, Sydow K. Effect of the phytogenic secretolytic drug Gelomyrtol forte on mucociliary clearance of the maxillary sinus. Laryngorhinootologie. 1995;74:733-7. doi: 10.1055/s-2007-997835
- Meister R, Wittig T, Beuscher N, de Mey C. Efficacy and tolerability of myrtol standardized in longterm treatment of chronic bronchitis. A double-blind, placebo-controlled study. Study Group Investigators. Arzneimittelforschung. 1999;49:351-8. doi: 10.1055/s-0031-1300426
- Gillissen A, Wittig T, Ehmen M, et al. A multi-centre, randomised, double-blind, placebo-controlled clinical trial on the efficacy and tolerability of GeloMyrtol(R) forte in acute bronchitis. Drug Res (Stuttg). 2013;63:19-27. doi: 10.1055/s-0032-1331182
- Federspil P, Wulkow R, Zimmermann T. Effects of standardized Myrtol in therapy of acute sinusitis - results of a double-blind, randomized multicenter study compared with placebo. Laryngorhinootologie. 1997;76:2377. doi: 10.1055/s-2007-997381
- Kehrl W, Sonnemann U, Dethlefsen U. Therapy for acute nonpurulent rhinosinusitis with cineole: results of a double-blind, randomized, placebo-controlled trial. Laryngoscope. 2004;114:738-42. DOI:10.1097/ 00005537-200404000-00027
- Paparoupa M, Gillissen A. Is Myrtol(R) standardized a new alternative toward antibiotics? Pharma-cogn Rev. 2016;10:143-6. doi: 10.4103/0973-7847.194045
- Aldoghaim FS, Flematti GR, Hammer KA. Antimicrobial activity of several ineole-rich Western Australian Eucalyptus essential oils. Microorganisms. 2018;6. doi: 10.3390/microorganisms6040122
- Yadav N, Chandra H. Suppression of inflammatory and infection responses in lung macrophages by eucalyptus oil and its constituent 1,8-cineole: role of pattern recognition receptors TREM-1 and NLRP3, the MAP kinase regulator MKP-1, and NFkappaB. PLoS One. 2017;12:e0188232. doi: 10.1371/journal.pone.0188232
- Juergens UR. Anti-inflammatory properties of the monoterpene 1.8-cineole: urrent evidence for co-medication in inflammatory airway diseases. Drug Res (Stuttg). 2014;64:638-46. doi: 10.1055/s-0034-1372609
- Tesche S, Metternich F, Sonnemann U, et al. The value of herbal medicines in the treatment of acute non-purulent rhinosinusitis. Results of a double-blind, randomised, controlled trial. Eur Arch Otorhinolaryngol. 2008;265:1355-9. doi: 10.1007/s00405-008-0683-z
- Bachert C, Thakur M, Weyers S, et al. Reporting clinical trial results of phytomedicines in acute rhinosinusitis: letter to the editor regarding Gottschlich S, Roschmann K, Candler H. Adv Ther (2018); 35:1023-1034. doi: 10.1007/s12325-018-0736-7. Adv Ther. 2019;36:1011-3. doi: 10.1007/s12325-019-00933-6
- Passali D, Spinosi MC, Crisanti A, Bellussi LM. Mometasone furoate nasal spray: a systematic review. Multidiscip Respir Med. 2016;11:18. doi: 10.1186/s40248-016-0054-3
- Meltzer EO, Charous BL, Busse WW, et al. Added relief in the treatment of acute recurrent sinusitis with adjunctive mometasone furoate nasal spray. The Nasonex Sinusitis Group. J Allergy Clin Immunol. 2000;106:630-7. doi: 10.1067/mai.2000.109056
- Nayak AS, Settipane GA, Pedinoff A, et al. Effective dose range of mometasone furoate nasal spray in the treatment of acute rhinosinusitis. Ann Allergy Asthma Immunol. 2002;89:271-8. doi: 10.1016/S1081-1206(10)61954-0
- Meltzer EO, Bachert C, Staudinger H. Treating acute rhinosinusitis: comparing efficacy and safety of mometasone furoate nasal spray, amoxicillin, and placebo. J Allergy Clin Immunol. 2005;116:1289-95. doi: 10.1016/j.jaci.2005.08.044
- Bachert C, Meltzer EO. Effect of mometasone furoate nasal spray on quality of life of patients with acute rhinosinusitis. Rhinology. 2007;45:190-6.
- Meltzer EO, Gates D, Bachert C. Mometasone furoate nasal spray increases the number of minimal-symptom days in patients with acute rhinosinusitis. Ann Allergy Asthma Immunol. 2012;108:275-9. doi: 10.1016/j.anai.2012.01.015
- Zalmanovici Trestioreanu A, Yaphe J. Intranasal steroids for acute sinusitis. Cochrane Database Syst Rev. 2013:CD005149. DOI:10.1002/ 14651858.CD005149.pub4
- Blasi F, Page C, Rossolini GM, et al. The effect of N-acetylcysteine on biofilms: implications for the treatment of respiratory tract infections. Respir Med. 2016;117:190-7. doi: 10.1016/j.rmed.2016.06.015
- Sadowska AM, Verbraecken J, Darquennes K, De Backer WA. Role of N-acetylcysteine in the management of COPD. Int J Chron Obstruct Pulmon Dis. 2006;1:425-34. doi: 10.2147/copd.2006.1.4.425
- Bahtouee M, Monavarsadegh G, Ahmadipour M, et al. Acetylcysteine in the treatment of subacute sinusitis: a double-blind placebo-controlled clinical trial. Ear Nose Throat J. 2017;96:E7-11. doi: 10.1177/014556131709600102.
Supplementary files
